NSEAnalysts/Institutional Investor Meet/Con. Call Updates30 Jul 2026 · 30 Jul 2026, 08:28 pm
Analysts/Institutional Investor Meet/Con. Call Updates
Mankind Pharma Limited · MANKIND
✦ AI SummaryResults
Mankind Pharma Limited has made available the audio recording of its Q1FY27 investor conference call on its website.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Mankind Pharma Limited has informed the Exchange about Link of Recording
Attachments (1)
📄pdf
Download →
MANKIND1_30072026202807_Audiorecording.pdf
View document text
July 30, 2026
BSE Limited National Stock Exchange of India Limited
P J Towers, Exchange Plaza, C-1, Block G,
Dalal Street, Bandra Kurla Complex,
Mumbai – 400 001 Bandra (E), Mumbai – 400 051
Scrip Code: 543904 Symbol: MANKIND
Dear Sir/ Madam,
Subject: Investor Conference Call for Q1FY27 – Audio Recording
Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015 and further to our intimation dated July 17, 2026 under subject
‘Intimation of Investor Conference Call for Q1FY27 with Senior Management of Mankind Pharma
Limited (“the Company”)’, the audio recording of the Call held today i.e. July 30, 2026 is available on
the website of the Company at: https://www.mankindpharma.com/wp-
content/uploads/2026/07/Mankind-Q1-FY27-Audio.mp3.
You are requested to kindly take the same on records.
Thanking You,
Yours Faithfully,
For Mankind Pharma Limited
Hitesh Kumar Jain
Company Secretary &
Compliance Officer